# Insurance & Spravato Coverage > Insurance and Spravato coverage on Long Island: most commercial plans accepted, IV ketamine is self-pay with superbills. No Medicaid plans accepted. - Type: informational - URL: https://zenintegrativecare.com/insurance-coverage/ - Updated: 2026-08-29T01:16:52+00:00 ## About this page Insurance and Spravato coverage on Long Island: most commercial plans accepted, IV ketamine is self-pay with superbills. No Medicaid plans accepted. ## Key facts - Phone: +1 (516) 610-0604 - Email: info@zenintegrativecare.com - Location: Carle Place, NY - Serving: Long Island, NY · New York City, NY · Nassau County, NY · Suffolk County, NY - Logo: /storage/projects/30/files/assets/852c08b1aec16f9a.webp ## Page content ## Insurance & Spravato Coverage on Long Island: A Modern Approach Please note: Zen Integrative Care does not accept Medicaid or Medicaid managed-care plans. We accept most major commercial insurance plans for Spravato and for psychiatric services. IV ketamine infusions are self-pay with superbills available for out-of-network reimbursement. Navigating the complexities of mental health treatment can be overwhelming, especially when traditional medications have failed to provide relief. For many residents across Nassau and Suffolk Counties, the emergence of esketamine (Spravato) represents a significant turning point in the management of… ## How It Works Spravato (esketamine) is an NMDA receptor antagonist that operates quite differently from standard Selective Serotonin Reuptake Inhibitors (SSRIs). Most traditional antidepressants focus on increasing the levels of naturally occurring chemicals in the brain, such as serotonin, norepinephrine, and dopamine. While these… The science behind this process centers on neuroplasticity. Chronic stress and depression can lead to the “withering” of synapses, the connections between neurons that allow for emotional regulation and cognitive function. Research indicates that esketamine helps to “re-wire” these pathways by increasing the… ## Who Is This Treatment For? Spravato is specifically indicated for adults who are struggling with Treatment-Resistant Depression (TRD) or Major Depressive Disorder (MDD) with acute suicidal ideation or behavior. It is designed to be used in conjunction with a daily oral antidepressant. If you have tried at least two different antidepressant… Individuals with Treatment-Resistant Depression: Those who have not found relief after trying multiple traditional antidepressant classes. ## What the Research Says The evidence supporting the use of esketamine has grown significantly over the last decade, with major contributions from institutions like Yale University, the National Institute of Mental Health (NIMH), and Johns Hopkins. Clinical trials have shown that esketamine can induce rapid and robust antidepressant effects… Published studies indicate that when used in combination with an oral antidepressant, Spravato significantly reduces the risk of relapse compared to an oral antidepressant alone. Long-term safety studies have also demonstrated that the treatment can be maintained over extended periods with a manageable side-effect… ## What to Expect at Our Clinic Your journey begins with a comprehensive consultation at our Long Island facility, where we review your psychiatric history and insurance details. Because Spravato coverage at our Long Island office coverage requires specific clinical documentation, our team handles the heavy lifting of the prior authorization… ## Related - [Ketamine Therapy on Long Island](https://zenintegrativecare.com/ketamine/) - [Mental Health](https://zenintegrativecare.com/mental-health/) - [Psychotherapy](https://zenintegrativecare.com/psychotherapy/) - [About Our Providers](https://zenintegrativecare.com/services/about-our-providers/) - [Telehealth Psychiatry & Medical Management](https://zenintegrativecare.com/telehealth-ketamine/)